The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease non-cystic fibrosis bronchiectasis (NCFB). The US regulator cleared DPP1 ...

Introduction Current bronchiectasis guidelines advise against the use of inhaled corticosteroids (ICS) except in patients with associated asthma, allergic bronchopulmonary aspergillosis (ABPA) and/or ...

This is a stand-alone, command-line version of some of the tools available in "ACBR - Comic Book Reader". It was made as a quick test to see if some of the code from ACBR could be used to make a basic ...

The new British Thoracic Society (BTS) Guideline for Bronchiectasis in Adults has been published. This article provides a summary of key highlights of the new BTS Guideline and covers who to ...

Pulmonary hygiene can help people with lung diseases to remove mucus. Controlled coughing is a key method of airway clearance in lung disease. Pulmonary hygiene may shorten hospital stays for people ...

Non-tuberculous mycobacteria isolates from patients with chronic pulmonary disease and no epidemiological relationship show sequence clusters through whole-genome sequencing Marc Rubio Mariana ...